dr. locke discusses the impact of the zuma-1 trial in nhl
Published 6 years ago • 58 plays • Length 0:55Download video MP4
Download video MP3
Similar videos
-
1:50
dr. locke discusses long-term follow-up of zuma-1 trial for nhl
-
1:23
dr. locke on the zuma-i trial of kte-c19
-
1:01
frederick locke, md, explains the zuma-1 results and what it means to dlbcl patients
-
1:13
dr. neelapu on primary results of the zuma-1 trial in nhl
-
2:22
frederick locke, md, summarizes outcomes from the zuma-1 clinical trial presented at ash 2020
-
1:52
long-term results of zuma-1 trial for patients with nhl
-
1:08
dr. locke on the zuma-6 trial of axi-cel with atezolizumab for dlbcl
-
2:54
non-hodgkin's lymphoma treatment expectations
-
5:49
immunotherapy clinical trial puts non-hodgkin lymphoma cancer in remission
-
21:26
symptoms and treatments in women with adrenoleukodystrophy (ald) - dr florian eichler
-
1:07
dr. winter discusses the zuma-7 trial in dlbcl
-
2:02
discussing the results from the zuma-1 trial for patients with advanced lymphoma
-
2:24
dr. neelapu on axi-cel in the zuma-1 trial for refractory aggressive non-hodgkin lymphoma
-
1:14
results of the zuma-1 trial exploring kte-c19 in nhl
-
8:01
high-risk lymphoma: the zuma-1 and scholar-1 trials
-
1:17
sattva neelapu, md, explains what the results of zuma-1 mean to dlbcl patients
-
0:53
design of the zuma-1 trial in non-hodgkin lymphoma
-
2:24
zuma-1: a pivotal trial of axicabtagene ciloleucel (axi-cel; kte-c19) in patients with nhl
-
1:34
dr. neelapu on interim results of the phase ii zuma-1 study in dlbcl
-
4:52
long term follow up on the zuma-1 trial for nhl
-
4:19
the pivotal zuma-1 trial for nhl
-
2:02
dr. neelapu on updated zuma-1 findings in non-hodgkin lymphoma